Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - 23 hours ago

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Weight loss drugs could help patients struggling with addiction, study says

A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.

Weight loss drugs could help with alcohol, opioid addiction, study says

Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners. The pharmaceutical company behind injectable weight-loss drugs has been ...

World - The Guardian - October 16

Weight loss drugs may help reduce drug and alcohol misuse: Research

Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...

Politics - The Hill - October 17

Roku’s stock sinks after streaming company posts another quarterly loss

Roku Inc.’s stock fell in after-hours trade Wednesday, after the streaming platform posted another quarterly loss and flat average revenue per user.

Business - MarketWatch - October 31

NHS needs better plan around weight loss jabs, warn experts

Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Weight-loss drugs show promise in tackling opioid and alcohol abuse

Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes

World - Financial Times - October 17

Weight loss injections: How do drugs like Wegovy and Mounjaro work?

NHS experts report unprecedented demand for the new generation of obesity treatments.

Weight-loss drugs could be key in lowering US obesity rates – experts

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts. Obesity rates have decreased slightly in the US and while it’s too early to say whether the ...

World - The Guardian - October 18

How will weight-loss drugs change our relationship with food?

The rise of these treatments has major implications for how we think about obesity, says James Gallagher.

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - 4 hours ago

Teva Fined Around $500 Million Over MS Drug Competition Concerns

The European Union fined Israel’s Teva Pharmaceutical 462.6 million euros, saying it abused its market position in a way that might have delayed competitors from entering the multiple sclerosis ...

Business - The Wall Street Journal - October 31

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.

Business - MarketWatch - November 5

Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.

World - The New York Times - October 15

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.

Business - CNBC - October 15

Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

Business - MarketWatch - October 19

From fashion to the food industry: 11 ways that weight-loss drugs have changed the world

The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?. For a phenomenon that has such visible results, there is huge ...

World - The Guardian - October 20

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

Science - The New York Times - Yesterday

Weight loss jabs for jobless not dystopian, says Wes Streeting

The government is looking into whether weight-loss drugs can help get more people back to work.

Weight Loss Jabs for Jobs?

Health Secretary says jabs could be given to help people get back into work.

23andMe’s stock falls after company says there’s substantial doubt it can stay in business

Shares of 23andMe fell 4% Tuesday after the DNA-testing company reported its latest quarterly loss and included “going concern” language in its financial statements, shedding gains made late Monday ...

Business - MarketWatch - Yesterday

Ford sees another $1 billion EV loss, lowers guidance and its stock falls 6%

Ford Motor Co. reported earnings late Monday, but investors looked past a beat.

Business - MarketWatch - October 28

AutoNation’s stock falls after earnings fall short of estimates

The new- and used-car retailer is still feeling the impact of a recent dealership-software outage.

Business - MarketWatch - October 25

Concerns raised over access to UK Biobank data after ‘race scientists’ claims

Expert says any suggestion of Human Diversity Foundation accessing sensitive data could affect public trust in science. Concerns have been raised about access to a scientific trove containing the ...

World - The Guardian - October 25

Latest in Amgen says no concerns around weight loss drug’s bone density data after stock falls